A VM 26‐based regimen for patients with previously untreated non‐Hodgkin lymphoma. Prolonged disease‐free survival in patients younger than 60 years of age: A phase II trial of the eastern cooperative oncology group
Leo I. Gordon*, Janet Andersen, Stephanie Gregory, Joseph Mazza, Paul Chervenick, Richard G. Hahn, Michael J. O'Connell
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A VM 26‐based regimen for patients with previously untreated non‐Hodgkin lymphoma. Prolonged disease‐free survival in patients younger than 60 years of age: A phase II trial of the eastern cooperative oncology group'. Together they form a unique fingerprint.